Discovery of the nitric oxide signaling pathway and targets for drug development

Frontiers in Bioscience

Volumn 14, Issue 1, 2009, Pages 1-18

  Bryan, Nathan S ^a   Bian, Ka ^a,b   Murad, Ferid ^a,b,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c NONE   (United States)

Author keywords

Cardiovascular system; cyclicGMP; Diet; Nitrate; Nitric oxide; Nitrite; Nitrogen species; Review; Soluble guanylyl cyclase

Indexed keywords

CYCLIC GMP; NITRIC OXIDE;

ANIMAL; DRUG DESIGN; DRUG EFFECT; HUMAN; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CYCLIC GMP; DRUG DESIGN; HUMANS; NITRIC OXIDE; SIGNAL TRANSDUCTION;

EID: 63849246674     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3228     Document Type: Article

References (198)

1. Ignarro, L. J.; Buga, G. M.; Wood, K. S.; Byrns, R. E.; Chaudhuri, G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad Sci. USA 84:9265-9269;(1987)
2. Palmer, R. M. J.; Ferrige, A. G.; Moncada, S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526;(1987) (Pubitemid 17085822)
3. Moncada, S.; Higgs, A. The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012;(1993) (Pubitemid 24015045)
4. Arnold, W. P.; Mittal, C. K.; Katsuki, S.; Murad, F. Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. Proc. Natl. Acad Sci. USA 74:3203-3207;(1977) (Pubitemid 8180317)
5. Katsuki, S.; Arnold, W.; Mittal, C.; Murad, F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. Journal of cyclic nucleotide research 3:23-35;(1977) (Pubitemid 8078230)
6. Murad, F.; Mittal, C. K.; Arnold, W. P.; Katsuki, S.; Kimura, H. Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Advances in cyclic nucleotide research 9:145-158;(1978)
7. Murad, F.; Arnold, W. P.; Mittal, C. K.; Braughler, J. M. Properties and regulation of guanylate cyclase and some proposed functions for cyclic GMP. Advances in cyclic nucleotide research 11:175-204;(1979)
8. Furchgott, R. F.; Zawadzki, J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetycholine. Nature 288:373-376;(1980) (Pubitemid 11169009)
9. Murad, F. Cyclic guanosine monophosphate as a mediator of vasodilation. J. Clin. Invest. 78:1-5;(1986) (Pubitemid 16068173)
10. Deguchi, T.; Yoshioka, M. L-Arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells. J. Biol Chem 257:10147-10151;(1982) (Pubitemid 13251012)
11. Knowles, R. G.; Palacios, M.; Palmer, R. M. J.; Moncada, S. Formation of nitric oxide from L-arginine in the central nervous system: A transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad Sci. USA 86:5159-5162;(1989) (Pubitemid 19182253)
12. Tannenbaum, S. R.; Fett, D.; Young, V. R.; Land, P. D.; Bruce, W. R. Nitrite and nitrate are formed by endogenous synthesis in the human intestine. Science 200:1487-1488;(1978)
13. Stuehr, D. J.; Marletta, M. A. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad Sci. USA 82:7738-7742;(1985) (Pubitemid 16204424)
14. Liu, Q.; S. S., G. Binding sites of nitric oxide synthases. Methods Enzymol 268:311-324;(1996) (Pubitemid 26286373)
15. Moncada, S.; Palmer, R. M. J.; Higgs, A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142;(1991)
16. Xia, H.; Bredt, D. S. Cloned and expressed nitric oxide synthase proteins. Methods in enzymology 268:427-436;(1996) (Pubitemid 26286385)
17. Marletta, M. A. Another activation switch for endothelial nitric oxide synthase: why does it have to be so complicated? Trends in biochemical sciences 26:519-521;(2001) (Pubitemid 32823427)
18. Bredt, D. S. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free radical research 31:577-596;(1999)
19. White, K. A.; Marletta, M. A. Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry 31:6627-6631;(1992)
20. Abu-Soud, H. M.; Yoho, L. L.; Stuehr, D. J. Calmodulin controls neuronal nitric-oxide synthase by a dual mechanism. J Biol Chem. 269:32047-32050;(1994)
21. Abu-Soud, H. M.; Stuehr, D. J. Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proc. Natl. Acad Sci. USA 90:10769-10772;(1993) (Pubitemid 23347124)
22. Dinerman, J. L.; Lowenstein, C. J.; Snyder, S. H. Molecular Mechanisms of Nitric Oxide Regulation Potential Relevance to Cardiovascular Disease. Circulation Research 73:217-222;(1993) (Pubitemid 23212101)
23. Bredt, D. S.; Snyder, S. H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad Sci. USA 87:682-685;(1990)
24. Stamler, J. S.; Singel, D. J.; Loscalzo, J. Biochemistry of Nitric oxide and its redox-activated forms. Science 258:1898-1902;(1992) (Pubitemid 23026727)
25. Ignarro, L. J. Haem-Dependent Activation of Guanylate Cyclase and Cyclic GMP Formation by Endogenous Nitric Oxide: A Unique Transduction Mechanism for Transcellular Signalling. Pharmacology & Toxicology 67:1-7;(1990) (Pubitemid 20272678)
26. Ignarro, L. J.; Adams, J. B.; Horwitz, P. M.; Wood, K. S. Activation of Soluble Guanylate cyclase by NO-Hemoproteins Involves NO-Heme Exchange. J. Biol Chem 261:4997-5002;(1986)
27. Ignarro, L. J. Signal Transduction Mechanisms Involving Nitric Oxide. Biochemical Pharmacology 41:485-490;(1991)
28. Waldman, S. A.; Murad, F. Cyclic GMP Synthesis and Function. Pharmacol Rev 39:163-195;(1987)
29. Twort, C. H. C.; van Breemen, C. Cyclic Guanosine Monophosphate-Enhanced Sequestration of Ca2+ by Sarcoplasmic Reticulum in Vascular Smooth Muscle. Circulation Research 62:961-964;(1988)
30. Hathaway, D. R.; March, K. L.; Lash, J. A.; Adam, L. P.; Wilensky, R. L. Vascular Smooth Muscle: A review of the Molecular Basis of Contractility. Circulation 83:382-390;(1991)
31. Hathaway, D. R.; Konicki, M. V.; Coolican, S. A. Phosphorylation of Myosin Light Chain Kinase from Vascular Smooth Muscle by cAMP-and cGMP-dependent Protein Kinases. J Mol Cell Cardiol 17:841-850;(1985) (Pubitemid 16240156)
32. Sakuma, I.; Stuehr, D. J.; Gross, S. S.; Nathan, C.; Levi, R. Identification of arginine as a precursor of endotheliumderived relaxing factor. Proc. Natl. Acad Sci. USA 85:8664-8667;(1988) (Pubitemid 19025017)
33. Palmer, R. M. J.; Rees, D. D.; Ashton, D. S.; Moncada, S. L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Communs 153:1251-1256;(1988)
34. Radomski, M. W.; Palmer, R. M. J.; Moncada, S. An L-Arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad Sci. USA 87:5193-5197;(1990)
35. Sase, K.; Michel, T. Expression of Constitutive Endothelial Nitric Oxide Synthase in Human Blood Platelets. Life Sciences 57:2049-2055;(1995)
36. Salvemini, D.; De Nucci, G.; Gryglewski, R. J.; Vane, J. R. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide like factor. Proc. Natl. Acad Sci. USA 86:6328-6332;(1989) (Pubitemid 19210645)
37. Radomski, M. W.; Palmer, R. M. J.; Moncada, S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br. J. Pharmac 92:181-187;(1987) (Pubitemid 17134934)
38. Bednar, M. M.; Gross, C. E.; Howard, D. B.; Russell, S. R.; Thomas, G. R. Nitric Oxide reverses aspririn antagonism of t-PA Thrombolysis in a rabbit model of thromboembolic stroke. Experimental Neurology 146:513-517;(1997) (Pubitemid 27381858)
39. Marletta, M. A.; Yoon, P. S.; Iyengar, R.; Leaf, C. D.; Wishnok, J. S. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 27:8706-8711;(1988) (Pubitemid 19008186)
40. Yui, Y.; Hattori, R.; Kosuga, K.; Eizawa, H.; Hiki, K.; Ohkawa, S.; Ohnishi, K.; Terao, S.; Kawai, C. Calmodulinindependent nitric oxide synthase from rat polymorphonuclear neutrophils. J. Biol Chem 266:3369-3371;(1991) (Pubitemid 21909219)
41. Stuehr, D. J.; Marletta, M. A. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma. The Journal of Immunology 139:518-525;(1987) (Pubitemid 17104054)
42. Ding, A. H.; Nathan, C. F.; Stuehr, D. J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. The Journal of Immunology 141:2407-2412;(1988)
43. Cho, H. J.; Xie, Q.-w. X.; Calaycay, J.; Mumford, R. A.; Swiderek, K. M.; Lee, T. D.; Nathan, C. F. Calmodulin is a subunit of nitric oxide synthase from macrophages. J. Exp. Med 176:599-604;(1992)
44. Welch, G.; Loscalzo, J. Nitric oxide and the Cardiovascular System. J. Card Surg 9:361-371;(1994) (Pubitemid 24178030)
45. Xie, Q.-w. X.; Cho, H. J.; Calaycay, J.; Mumford, R. A.; Swiderek, K. M.; Lee, T. D.; Ding, A.; Troso, T.; Nathan, C. F. Cloning and Characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225-228;(1992)
46. Radomski, M. W.; Palmer, R. M. J.; Moncada, S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad Sci. USA 87:10043-10047;(1990) (Pubitemid 120016581)
47. Nathan, C. F.; Hibbs Jr, J. B. Role of Nitric Oxide synthesis in macrophage antimicrobial activity. Current Opinion in Immunology 3:65-70;(1991)
48. Stuehr, D. J.; Griffith, O. W. Mammalian nitric oxide synthases. Adv Enzymol Relat Areas Mol Biol 65:287-346;(1992)
49. Rodeberg, D. A.; Chaet, M. S.; Bass, R. C.; Arkovitz, M. S.; Garcia, V. F. Nitric Oxide: An Overview. The American Journal of Surgery 170:292-303;(1995)
50. Roerig, S.; Wolf, R.; Grisham, M. B. Nitric Oxide, Chronic Joint Inflammation, and Pain. In: Ignarro, L. J., ed. Nitric Oxide Biology and Pathobiology. San Diego: Academic Press; (2000):873-894.
51. Garthwaite, G.; Garthwaite, J. Differential dependence on Ca2+ of N-methyl-D-aspartate and quisqualate neurotoxicity in young rat hippocampal slices. Neuroscience Letters 97:316-322;(1989) (Pubitemid 19047478)
52. Lipton, S. A.; Choi, Y.-B.; Pan, Z.-H.; Lei, S. Z.; Chen, H.-S. V.; Sucher, N. J.; Loscalzo, J.; Singel, D. J.; Stamler, J. S. A redox based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso compounds. Nature 364:626-632;(1993) (Pubitemid 23274719)
53. Gillespie, J. S.; Liu, X.; Martin, W. The neurotransmitter of the non-adrenergic non-cholinergic inhibitory nerves to smooth muscle of the genital system. Elsevier Science Publishers BV; (1990)
54. Mersereau, W. A.; Hinchey, E. J. Effect of Gastric acidity on gastric ulceration induced by hemorrhage in the rat, utilizing a gastric chamber technique. Gastroenterology 64:1130-1135;(1973)
55. Ritchie, W. P.; Shearburn, E. W. Influence of isoproterenol and cholestyramine on acute gastric mucosal ulcerogenesis. Gastroenterology 73:62-65;(1977)
56. Whittle, B. J. R.; Boughton-Smith, N. K.; Moncada, S. Biosynthesis and role of th endothelium-derived vasodilator, nitric oxide, in the gastric mucosa. Ann NY Acad Sci 664:126-139;(1992) (Pubitemid 23022844)
57. Stark, M. E.; Szurszewski, J. H. Role of Nitric Oxide in Gastrointestinal and Hepatic Function and Disease. Gastroenterology 103:1928-1949;(1992)
58. Marsh, N.; Marsh, A. A short history of nitroglycerine and nitric oxide in pharmacology and physiology. Clinical and experimental pharmacology & physiology 27:313-319;(2000) (Pubitemid 30194171)
59. Zaher, C.; Goldberg, G. A.; Kadlubek, P. Estimating angina prevalence in a managed care population. The American journal of managed care 10:S339-346;(2004)
60. Leesar, M. A.; Stoddard, M. F.; Dawn, B.; Jasti, V. G.; Masden, R.; Bolli, R. Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation 103:2935-2941;(2001) (Pubitemid 32578131)
61. Lauretti, G. R.; Perez, M. V.; Reis, M. P.; Pereira, N. L. Double-blind evaluation of transdermal nitroglycerine as adjuvant to oral morphine for cancer pain management. Journal of clinical anesthesia 14:83-86;(2002) (Pubitemid 34275458)
62. Higa, M.; Takasu, N.; Tamanaha, T.; Nakamura, K.; Shimabukuro, M.; Sasara, T.; Tawata, M. Nitroglycerin spray rapidly improves pain in a patient with chronic painful diabetic neuropathy. Diabet Med 21:1053-1054;(2004) (Pubitemid 39215332)
63. Lindsey, I.; Jones, O. M.; Cunningham, C.; Mortensen, N. J. Chronic anal fissure. The British journal of surgery 91:270-279;(2004) (Pubitemid 38379655)
64. Loehe, F.; Preissler, G.; Annecke, T.; Bittmann, I.; Jauch, K. W.; Messmer, K. Continuous infusion of nitroglycerin improves pulmonary graft function of non-heart-beating donor lungs. Transplantation 77:1803-1808;(2004) (Pubitemid 38822200)
65. Baxter, K.; Howden, B. O.; Jablonski, P. Heart preservation with celsior solution improved by the addition of nitroglycerine. Transplantation 71:1380-1384;(2001) (Pubitemid 32507108)
66. Yasuda, H.; Yamaya, M.; Nakayama, K.; Sasaki, T.; Ebihara, S.; Kanda, A.; Asada, M.; Inoue, D.; Suzuki, T.; Okazaki, T.; Takahashi, H.; Yoshida, M.; Kaneta, T.; Ishizawa, K.; Yamanda, S.; Tomita, N.; Yamasaki, M.; Kikuchi, A.; Kubo, H.; Sasaki, H. Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV nonsmall-cell lung cancer. J Clin Oncol 24:688-694;(2006) (Pubitemid 46630435)
67. Janero, D. R.; Bryan, N. S.; Saijo, F.; Dhawan, V.; Schwalb, D. J.; Warren, M. C.; Feelisch, M. Differential nitros (yl) ation of blood and tissue constituents during glyceryl trinitrate biotransformation in vivo. Proc. Natl. Acad Sci. USA 101:16958-16963;(2004) (Pubitemid 39601346)
68. Ahlner, J.; Andersson, R. G.; Torfgard, K.; Axelsson, K. L. Organic nitrate esters: clinical use and mechanisms of actions. Pharmacol Rev 43:351-423;(1991)
69. Fung, H. L. Biochemical mechanism of nitroglycerin action and tolerance: is this old mystery solved? Annual review of pharmacology and toxicology 44:67-85;(2004)
70. Chen, Z.; Zhang, J.; Stamler, J. S. Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc. Natl. Acad Sci. USA 99:8306-8311;(2002) (Pubitemid 34651048)
71. Feelisch, M.; Noack, E. Nitric oxide (NO) formation from nitrovasodilators occurs independently of hemoglobin or nonheme iron. European journal of pharmacology 142:465-469;(1987) (Pubitemid 18063969)
72. Feelisch, M.; Kelm, M. Biotransformation of organic nitrates to nitric oxide by vascular smooth muscle and endothelial cells. Biochem Biophys Res Commun 180:286-293;(1991)
73. Russwurm, M.; Behrends, S.; Harteneck, C.; Koesling, D. Functional properties of a naturally occurring isoform of soluble guanylyl cyclase. The Biochemical journal 335(Pt 1):125-130;(1998) (Pubitemid 28477058)
74. Budworth, J.; Meillerais, S.; Charles, I.; Powell, K. Tissue distribution of the human soluble guanylate cyclases. Biochem Biophys Res Communs 263:696-701;(1999) (Pubitemid 29490689)
75. Mergia, E.; Russwurm, M.; Zoidl, G.; Koesling, D. Major occurrence of the new alpha2beta1 isoform of NO-sensitive guanylyl cyclase in brain. Cellular signalling 15:189-195;(2003) (Pubitemid 35449122)
76. Nimmegeers, S.; Sips, P.; Buys, E.; Brouckaert, P.; Van de Voorde, J. Functional role of the soluble guanylyl cyclase alpha (1) subunit in vascular smooth muscle relaxation. Cardiovascular research 76:149-159;(2007) (Pubitemid 47362046)
77. Lucas, K. A.; Pitari, G. M.; Kazerounian, S.; Ruiz-Stewart, I.; Park, J.; Schulz, S.; Chepenik, K. P.; Waldman, S. A. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52:375-414;(2000)
78. Biel, M.; Seeliger, M.; Pfeifer, A.; Kohler, K.; Gerstner, A.; Ludwig, A.; Jaissle, G.; Fauser, S.; Zrenner, E.; Hofmann, F. Selective loss of cone function in mice lacking the cyclic nucleotide-gated channel CNG3. Proc. Natl. Acad Sci. USA 96:7553-7557;(1999) (Pubitemid 29299700)
79. Boolell, M.; Allen, M. J.; Ballard, S. A.; Gepi-Attee, S.; Muirhead, G. J.; Naylor, A. M.; Osterloh, I. H.; Gingell, C. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. International journal of impotence research 8:47-52;(1996)
80. Humbert, P.; Niroomand, F.; Fischer, G.; Mayer, B.; Koesling, D.; Hinsch, K. D.; Gausepohl, H.; Frank, R.; Schultz, G.; Bohme, E. Purification of soluble guanylyl cyclase from bovine lung by a new immunoaffinity chromatographic method. European journal of biochemistry/FEBS 190:273-278;(1990) (Pubitemid 20201512)
81. Lee, Y. C.; Martin, E.; Murad, F. Human recombinant soluble guanylyl cyclase: expression, purification, and regulation. Proc. Natl. Acad Sci. USA 97:10763-10768;(2000)
82. Conti, M. Phosphodiesterases and cyclic nucleotide signaling in endocrine cells. Molecular endocrinology (Baltimore, Md 14:1317-1327;(2000)
83. Corbin, J. D.; Francis, S. H.; Webb, D. J. Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction. Urology 60:4-11;(2002) (Pubitemid 35300142)
84. Friebe, A.; Mergia, E.; Dangel, O.; Lange, A.; Koesling, D. Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase. Proc. Natl. Acad Sci. USA 104:7699-7704;(2007) (Pubitemid 47185969)
85. Mergia, E.; Friebe, A.; Dangel, O.; Russwurm, M.; Koesling, D. Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system. J. Clin. Invest. 116:1731-1737;(2006)
86. Pyriochou, A.; Papapetropoulos, A. Soluble guanylyl cyclase: more secrets revealed. Cellular signalling 17:407-413;(2005) (Pubitemid 39643059)
87. Krumenacker, J. S.; Hyder, S. M.; Murad, F. Estradiol rapidly inhibits soluble guanylyl cyclase expression in rat uterus. Proc. Natl. Acad Sci. USA 98:717-722;(2001) (Pubitemid 32105109)
88. Kloss, S.; Srivastava, R.; Mulsch, A. Down-regulation of soluble guanylyl cyclase expression by cyclic AMP is mediated by mRNA-stabilizing protein HuR. Molecular pharmacology 65:1440-1451;(2004) (Pubitemid 38668302)
89. Papapetropoulos, A.; Marczin, N.; Mora, G.; Milici, A.; Murad, F.; Catravas, J. D. Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents. Hypertension 26:696-704;(1995)
90. Papapetropoulos, A.; Abou-Mohamed, G.; Marczin, N.; Murad, F.; Caldwell, R. W.; Catravas, J. D. Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1 beta. British journal of pharmacology 118:1359-1366;(1996) (Pubitemid 26248784)
91. Papapetropoulos, A.; Go, C. Y.; Murad, F.; Catravas, J. D. Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells. British journal of pharmacology 117:147-155;(1996) (Pubitemid 26030264)
92. Kimura, H.; Murad, F. Evidence for two different forms of guanylate cyclase in rat heart. J. Biol Chem 249:6910-6916;(1974)
93. Behrends, S.; Harteneck, C.; Schultz, G.; Koesling, D. A variant of the alpha 2 subunit of soluble guanylyl cyclase contains an insert homologous to a region within adenylyl cyclases and functions as a dominant negative protein. J. Biol Chem 270:21109-21113;(1995)
94. Behrends, S.; Vehse, K. The beta (2) subunit of soluble guanylyl cyclase contains a human-specific frameshift and is expressed in gastric carcinoma. Biochem Biophys Res Communs 271:64-69;(2000) (Pubitemid 30444857)
95. Chhajlani, V.; Frandberg, P. A.; Ahlner, J.; Axelsson, K. L.; Wikberg, J. E. Heterogeneity in human soluble guanylate cyclase due to alternative splicing. FEBS letters 290:157-158;(1991)
96. Okamoto, H. Molecular cloning of a novel variant of the rat soluble guanylate cyclase beta2 subunit. The international journal of biochemistry & cell biology 36:472-480;(2004) (Pubitemid 37542445)
97. Ritter, D.; Taylor, J. F.; Hoffmann, J. W.; Carnaghi, L.; Giddings, S. J.; Zakeri, H.; Kwok, P. Y. Alternative splicing for the alpha1 subunit of soluble guanylate cyclase. The Biochemical journal 346 Pt 3:811-816;(2000) (Pubitemid 30171045)
98. Evgenov, O. V.; Pacher, P.; Schmidt, P. M.; Hasko, G.; Schmidt, H. H.; Stasch, J. P. NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov 5:755-768;(2006) (Pubitemid 44323702)
99. Martin, E.; Lee, Y. C.; Murad, F. YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components. Proc. Natl. Acad Sci. USA 98:12938-12942;(2001) (Pubitemid 33051298)
100. Bryan, N. S.; Calvert, J. W.; Elrod, J. W.; Gundewar, S.; Ji, S. Y.; Lefer, D. J. Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury. Proc. Natl. Acad Sci. USA 104:19144-19149;(2007)
101. Bryan, N. S.; Fernandez, B. O.; Bauer, S. M.; Garcia-Saura, M. F.; Milsom, A. B.; Rassaf, T.; Maloney, R. E.; Bharti, A.; Rodriguez, J.; Feelisch, M. Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat Chem Biol 1:290-297;(2005)
102. Zweier, J. L.; Wang, P.; Samouilov, A.; Kuppusamy, P. Enzyme-independent formation of nitric oxide in biological tissues. Nat Med 1:804-809;(1995)
103. Lundberg, J. O.; Weitzberg, E.; Lundberg, J. M.; Alving, K. Intragastric nitric oxide production in humans: measurements in expelled air. Gut 35:1543-1546;(1994) (Pubitemid 24339249)
104. Benjamin, N.; O'Driscoll, F.; Dougall, H.; Duncan, C.; Smith, L.; Golden, M.; McKenzie, H. Stomach NO synthesis. Nature 368:502;(1994)
105. Lundberg, J. O.; Weitzberg, E.; Gladwin, M. T. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov; (2008)
106. Kleinbongard, P.; Dejam, A.; Lauer, T.; Rassaf, T.; Schindler, A.; Picker, O.; Scheeren, T.; Godecke, A.; Schrader, J.; Schulz, R.; Heusch, G.; Schaub, G. A.; Bryan, N. S.; Feelisch, M.; Kelm, M. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med 35:790-796;(2003) (Pubitemid 37329482)
107. Gladwin, M. T.; Schechter, A. N.; Kim-Shapiro, D. B.; Patel, R. P.; Hogg, N.; Shiva, S.; Cannon, R. O., 3rd; Kelm, M.; Wink, D. A.; Espey, M. G.; Oldfield, E. H.; Pluta, R. M.; Freeman, B. A.; Lancaster, J. R., Jr.; Feelisch, M.; Lundberg, J. O. The emerging biology of the nitrite anion. Nat Chem Biol 1:308-314;(2005)
108. Bryan, N. S. Nitrite in nitric oxide biology: Cause or consequence? A systems-based review. Free Radic Biol Med 41:691-701;(2006) (Pubitemid 44163410)
109. Tannenbaum, S. R.; Sinskey, A. J.; Weisman, M.; Bishop, W. Nitrite in human saliva. Its possible relationship to nitrosamine formation. J Natl Cancer Inst 53:79-84;(1974)
110. van Maanen, J. M.; van Geel, A. A.; Kleinjans, J. C. Modulation of nitrate-nitrite conversion in the oral cavity. Cancer Detect Prev 20:590-596;(1996) (Pubitemid 27017069)
111. Bryan, N. S.; Rassaf, T.; Maloney, R. E.; Rodriguez, C. M.; Saijo, F.; Rodriguez, J. R.; Feelisch, M. Cellular Targets and Mechanisms of Nitros (yl) ation: An Insight into Their Nature and Kinetics in vivo. Proc. Natl. Acad Sci. USA 101:4308-4313;(2004) (Pubitemid 38405925)
112. Zweier, J. L.; Wang, P.; Samouilov, A.; Kuppusamy, P. Enzyme-independent formation of nitric oxide in biological tissues. Nat Med 1:804-809;(1995)
113. Lundberg, J. O.; Weitzberg, E. NO generation from nitrite and its role in vascular control. Arterioscler Thromb Vasc Biol 25:915-922;(2005) (Pubitemid 40627834)
114. Walters, C. L.; Casselden, R. J.; Taylor, A. M. Nitrite metabolism by skeletal muscle mitochondria in relation to haem pigments. Biochim Biophys Acta 143:310-318;(1967)
115. Reutov, V. P.; Sorokina, E. G. NO-synthase and nitritereductase components of nitric oxide cycle. Biochemistry (Mosc) 63:874-884;(1998) (Pubitemid 128588117)
116. Kozlov, A. V.; Staniek, K.; Nohl, H. Nitrite reductase activity is a novel function of mammalian mitochondria. FEBS Lett 454:127-130;(1999) (Pubitemid 29296938)
117. Cosby, K.; Partovi, K. S.; Crawford, J. H.; Patel, R. P.; Reiter, C. D.; Martyr, S.; Yang, B. K.; Waclawiw, M. A.; Zalos, G.; Xu, X.; Huang, K. T.; Shields, H.; Kim-Shapiro, D. B.; Schechter, A. N.; Cannon, R. O., 3rd; Gladwin, M. T. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 9:1498-1505;(2003) (Pubitemid 38004777)
118. Rassaf, T.; Flogel, U.; Drexhage, C.; Hendgen-Cotta, U.; Kelm, M.; Schrader, J. Nitrite reductase function of deoxymyoglobin: oxygen sensor and regulator of cardiac energetics and function. Circ Res 100:1749-1754;(2007) (Pubitemid 46987867)
119. Li, H.; Samouilov, A.; Liu, X.; Zweier, J. L. Characterization of the effects of oxygen on xanthine oxidasemediated nitric oxide formation. J Biol Chem 279:16939-16946;(2004) (Pubitemid 38560446)
120. Alikulov, Z. A.; L'Vov N, P.; Kretovich, V. L. [Nitrate and nitrite reductase activity of milk xanthine oxidase]. Biokhimiia 45:1714-1718;(1980)
121. Webb, A.; Bond, R.; McLean, P.; Uppal, R.; Benjamin, N.; Ahluwalia, A. Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc Natl Acad Sci U S A 101:13683-13688;(2004) (Pubitemid 39238463)
122. Duranski, M. R.; Greer, J. J.; Dejam, A.; Jaganmohan, S.; Hogg, N.; Langston, W.; Patel, R. P.; Yet, S. F.; Wang, X.; Kevil, C. G.; Gladwin, M. T.; Lefer, D. J. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest 115:1232-1240;(2005) (Pubitemid 40629041)
123. Pluta, R. M.; Dejam, A.; Grimes, G.; Gladwin, M. T.; Oldfield, E. H. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. Jama 293:1477-1484;(2005) (Pubitemid 40393292)
124. Hunter, C. J.; Dejam, A.; Blood, A. B.; Shields, H.; Kim-Shapiro, D. B.; Machado, R.; Tarekegn, S.; Mulla, N.; Hopper, A. O.; Schechter, A. N.; Power, G. G.; Gladwin, M. T. Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator. Nat Med 10:1122-1127;(2004) (Pubitemid 39424875)
125. Hardwick, J. B.; Tucker, A. T.; Wilks, M.; Johnston, A.; Benjamin, N. A novel method for the delivery of nitric oxide therapy to the skin of human subjects using a semi-permeable membrane. Clin Sci (Lond) 100:395-400;(2001) (Pubitemid 32324337)
126. Duncan, C.; Dougall, H.; Johnston, P.; Green, S.; Brogan, R.; Leifert, C.; Smith, L.; Golden, M.; Benjamin, N. Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat Med 1:546-551;(1995)
127. Dykhuizen, R. S.; Frazer, R.; Duncan, C.; Smith, C. C.; Golden, M.; Benjamin, N.; Leifert, C. Antimicrobial effect of acidified nitrite on gut pathogens: importance of dietary nitrate in host defense. Antimicrob Agents Chemother 40:1422-1425;(1996) (Pubitemid 26169053)
128. Bjorne, H. H.; Petersson, J.; Phillipson, M.; Weitzberg, E.; Holm, L.; Lundberg, J. O. Nitrite in saliva increases gastric mucosal blood flow and mucus thickness. J Clin Invest 113:106-114;(2004) (Pubitemid 38541637)
129. Tsuchiya, K.; Kanematsu, Y.; Yoshizumi, M.; Ohnishi, H.; Kirima, K.; Izawa, Y.; Shikishima, M.; Ishida, T.; Kondo, S.; Kagami, S.; Takiguchi, Y.; Tamaki, T. Nitrite is an alternative source of NO in vivo. Am J Physiol Heart Circ Physiol 288:H2163-2170;(2005) (Pubitemid 40604101)
130. Kleinbongard, P.; Dejam, A.; Lauer, T.; Jax, T.; Kerber, S.; Gharini, P.; Balzer, J.; Zotz, R. B.; Scharf, R. E.; Willers, R.; Schechter, A. N.; Feelisch, M.; Kelm, M. Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans. Free Radic Biol Med 40:295-302;(2006) (Pubitemid 43069353)
131. Lundberg, J. O.; Govoni, M. Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radic Biol Med 37:395-400;(2004) (Pubitemid 38834005)
132. Duncan, C.; Dougall, H.; Johnston, P.; Green, S.; Brogan, R.; Leifert, C.; Smith, L.; Golden, M.; Benjamin, N. Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat Med 1:546-551;(1995)
133. Spiegelhalder, B.; Eisenbrand, G.; Preussmann, R. Influence of dietary nitrate on nitrite content of human saliva: possible relevance to in vivo formation of N-nitroso compounds. Food Cosmet Toxicol 14:545-548;(1976) (Pubitemid 8050597)
134. Lundberg, J. O.; Weitzberg, E.; Cole, J. A.; Benjamin, N. Nitrate, bacteria and human health. Nat Rev Microbiol 2:593-602;(2004) (Pubitemid 39200033)
135. Larsen, F. J.; Ekblom, B.; Sahlin, K.; Lundberg, J. O.; Weitzberg, E. Effects of dietary nitrate on blood pressure in healthy volunteers. The New England journal of medicine 355:2792-2793;(2006) (Pubitemid 46021534)
136. Webb, A. J.; Patel, N.; Loukogeorgakis, S.; Okorie, M.; Aboud, Z.; Misra, S.; Rashid, R.; Miall, P.; Deanfield, J.; Benjamin, N.; MacAllister, R.; Hobbs, A. J.; Ahluwalia, A. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 51:784-790;(2008) (Pubitemid 351301536)
137. Pennington, J. A. T. Dietary exposure models for nitrates and nitrites. Food Control 9:385-395;(1998) (Pubitemid 128181662)
138. Bartsch, H.; Montesano, R. Relevance of nitrosamines to human cancer. Carcinogenesis 5:1381-1393;(1984) (Pubitemid 15218943)
139. Craddock, V. M. Nitrosamines and human cancer: proof of an association? Nature 306:638;(1983)
140. Ward, M. H.; deKok, T. M.; Levallois, P.; Brender, J.; Gulis, G.; Nolan, B. T.; Van Derslice, J. Workgroup report: Drinking-water nitrate and health-recent findings and research needs. Environmental health perspectives 113:1607-1614;(2005) (Pubitemid 41614919)
141. Program, N. T. On The Toxicology and Carcinogenesis Studues of Sodium Nitrite. In: Services, U. S. D. o. H. a. H., ed.: National Institute of Health; (2001):1-276.
142. Erzurum, S. C.; Ghosh, S.; Janocha, A. J.; Xu, W.; Bauer, S.; Bryan, N. S.; Tejero, J.; Hemann, C.; Hille, R.; Stuehr, D. J.; Feelisch, M.; Beall, C. M. Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans. Proc. Natl. Acad Sci. USA 104:17593-17598;(2007) (Pubitemid 350210880)
143. Stamler, J. S.; Lamas, S.; Fang, F. C. Nitrosylation. The prototypic redox-based signaling mechanism. Cell 106:675-683;(2001) (Pubitemid 32900659)
144. Ignarro, L. J.; Lippton, H.; Edwards, J. C.; Baricos, W. H.; Hyman, A. L.; Kadowitz, P. J.; Gruetter, C. A. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. The Journal of pharmacology and experimental therapeutics 218:739-749;(1981) (Pubitemid 11005147)
145. Foster, M. W.; McMahon, T. J.; Stamler, J. S. S-nitrosylation in health and disease. Trends in molecular medicine 9:160-168;(2003) (Pubitemid 36626705)
146. Angelo, M.; Singel, D. J.; Stamler, J. S. An S-nitrosothiol (SNO) synthase function of hemoglobin that utilizes nitrite as a substrate. Proc. Natl. Acad Sci. USA 103:8366-8371;(2006) (Pubitemid 43838461)
147. Massy, Z. A.; Fumeron, C.; Borderie, D.; Tuppin, P.; Nguyen-Khoa, T.; Benoit, M. O.; Jacquot, C.; Buisson, C.; Drueke, T. B.; Ekindjian, O. G.; Lacour, B.; Iliou, M. C. Increased pasma S-nitrosothiol concentrations predict cardiovascular outcomes among patients with end-stage renal disease: a prospective study. J Am Soc Nephrol 15:470-476;(2004) (Pubitemid 38140789)
148. Heiss, C.; Lauer, T.; Dejam, A.; Kleinbongard, P.; Hamada, S.; Rassaf, T.; Matern, S.; Feelisch, M.; Kelm, M. Plasma nitroso compounds are decreased in patients with endothelial dysfunction. Journal of the American College of Cardiology 47:573-579;(2006) (Pubitemid 43170846)
149. Lane, P.; Hao, G.; Gross, S. S. S-nitrosylation is emerging as a specific and fundamental posttranslational protein modification: head-to-head comparison with O-phosphorylation. Sci STKE 2001:RE1;(2001)
150. Stamler, J. S.; Simon, D. I.; Osborne, J. A.; Mullins, M. E.; Jaraki, O.; Michel, T.; Singel, D. J.; Loscalzo, J. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad Sci. USA 89:444-448;(1992)
151. Hess, D. T.; Matsumoto, A.; Kim, S. O.; Marshall, H. E.; Stamler, J. S. Protein S-nitrosylation: purview and parameters. Nature reviews 6:150-166;(2005) (Pubitemid 40215810)
152. Hara, M. R.; Agrawal, N.; Kim, S. F.; Cascio, M. B.; Fujimuro, M.; Ozeki, Y.; Takahashi, M.; Cheah, J. H.; Tankou, S. K.; Hester, L. D.; Ferris, C. D.; Hayward, S. D.; Snyder, S. H.; Sawa, A. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nature cell biology 7:665-674;(2005) (Pubitemid 40975747)
153. Whalen, E. J.; Foster, M. W.; Matsumoto, A.; Ozawa, K.; Violin, J. D.; Que, L. G.; Nelson, C. D.; Benhar, M.; Keys, J. R.; Rockman, H. A.; Koch, W. J.; Daaka, Y.; Lefkowitz, R. J.; Stamler, J. S. Regulation of beta-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2. Cell 129:511-522;(2007) (Pubitemid 46660966)
154. Kelleher, Z. T.; Matsumoto, A.; Stamler, J. S.; Marshall, H. E. NOS2 regulation of NF-kappaB by S-nitrosylation of p65. J Biol Chem 282:30667-30672;(2007) (Pubitemid 350035227)
155. Cammack, R.; Joannou, C. L.; Cui, X. Y.; Torres Martinez, C.; Maraj, S. R.; Hughes, M. N. Nitrite and nitrosyl compounds in food preservation. Biochim Biophys Acta 1411:475-488;(1999) (Pubitemid 29221968)
156. Kashiba-Iwatsuki, M.; Kitoh, K.; Kasahara, E.; Yu, H.; Nisikawa, M.; Matsuo, M.; Inoue, M. Ascorbic acid and reducing agents regulate the fates and functions of S-nitrosothiols. Journal of biochemistry 122:1208-1214;(1997) (Pubitemid 28019987)
157. Dicks, A. P.; Williams, D. L. Generation of nitric oxide from S-nitrosothiols using protein-bound Cu2+ sources. Chemistry & biology 3:655-659;(1996) (Pubitemid 26351774)
158. Liu, L.; Hausladen, A.; Zeng, M.; Que, L.; Heitman, J.; Stamler, J. S. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature 410:490-494;(2001) (Pubitemid 32240051)
159. Gow, A. J.; Buerk, D. G.; Ischiropoulos, H. A novel reaction mechanism for the formation of S-nitrosothiol in vivo. J Biol Chem 272:2841-2845;(1997) (Pubitemid 27053331)
160. Inoue, K.; Akaike, T.; Miyamoto, Y.; Okamoto, T.; Sawa, T.; Otagiri, M.; Suzuki, S.; Yoshimura, T.; Maeda, H. Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo. J Biol Chem 274:27069-27075;(1999)
161. Liu, L.; Yan, Y.; Zeng, M.; Zhang, J.; Hanes, M. A.; Ahearn, G.; McMahon, T. J.; Dickfeld, T.; Marshall, H. E.; Que, L. G.; Stamler, J. S. Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell 116:617-628;(2004) (Pubitemid 38264436)
162. Que, L. G.; Liu, L.; Yan, Y.; Whitehead, G. S.; Gavett, S. H.; Schwartz, D. A.; Stamler, J. S. Protection from experimental asthma by an endogenous bronchodilator. Science 308:1618-1621;(2005) (Pubitemid 40807509)
163. Murad, F. Cellular signaling with nitric oxide and cyclic GMP. Braz J Med Biol Res 32:1317-1327;(1999) (Pubitemid 129544249)
164. Pacher, P.; Beckman, J. S.; Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315-424;(2007) (Pubitemid 46217686)
165. Turko, I. V.; Murad, F. Protein nitration in cardiovascular diseases. Pharmacol Rev 54:619-634;(2002) (Pubitemid 35351199)
166. Souza, J. M.; Daikhin, E.; Yudkoff, M.; Raman, C. S.; Ischiropoulos, H. Factors determining the selectivity of protein tyrosine nitration. Arch Biochem Biophys 371:169-178;(1999)
167. Wu, W.; Chen, Y.; Hazen, S. L. Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem 274:25933-25944;(1999)
168. Sampson, J. B.; Ye, Y.; Rosen, H.; Beckman, J. S. Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide. Arch Biochem Biophys 356:207-213;(1998) (Pubitemid 28387725)
169. Eiserich, J. P.; Hristova, M.; Cross, C. E.; Jones, A. D.; Freeman, B. A.; Halliwell, B.; van der Vliet, A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391:393-397;(1998) (Pubitemid 28093514)
170. Thukkani, A. K.; McHowat, J.; Hsu, F. F.; Brennan, M. L.; Hazen, S. L.; Ford, D. A. Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions. Circulation 108:3128-3133;(2003) (Pubitemid 38031803)
171. Bian, K.; Davis, K.; Kuret, J.; Binder, L.; Murad, F. Nitrotyrosine formation with endotoxin-induced kidney injury detected by immunohistochemistry. Am J Physiol 277:F33-40;(1999) (Pubitemid 29352672)
172. Bian, K.; Murad, F. Diversity of endotoxin-induced nitrotyrosine formation in macrophage-endothelium-rich organs. Free Radic Biol Med 31:421-429;(2001) (Pubitemid 32728429)
173. Eiserich, J. P.; Cross, C. E.; Jones, A. D.; Halliwell, B.; van der Vliet, A. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification. J Biol Chem 271:19199-19208;(1996) (Pubitemid 26271585)
174. Daugherty, A.; Dunn, J. L.; Rateri, D. L.; Heinecke, J. W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94:437-444;(1994) (Pubitemid 24218123)
175. Carr, A. C.; Frei, B. The nitric oxide congener nitrite inhibits myeloperoxidase/H2O2/Cl-mediated modification of low density lipoprotein. J Biol Chem 276:1822-1828;(2001) (Pubitemid 32109656)
176. Fraga, C. G.; Oteiza, P. I. Iron toxicity and antioxidant nutrients. Toxicology 180:23-32;(2002) (Pubitemid 35248090)
177. Viner, R. I.; Ferrington, D. A.; Aced, G. I.; Miller-Schlyer, M.; Bigelow, D. J.; Schoneich, C. In vivo aging of rat skeletal muscle sarcoplasmic reticulum Ca-ATPase. Chemical analysis and quantitative simulation by exposure to low levels of peroxyl radicals. Biochim Biophys Acta 1329:321-335;(1997) (Pubitemid 27466821)
178. Bian, K.; Gao, Z.; Weisbrodt, N.; Murad, F. The nature of heme/iron-induced protein tyrosine nitration. Proc Natl Acad Sci U S A 100:5712-5717;(2003) (Pubitemid 36576873)
179. Zhang, B. Q.; Hu, S. J.; Qiu, L. H.; Shan, Q. X.; Sun, J.; Xia, Q.; Bian, K. Diphasic effects of Astragalus membranaceus BUNGE (Leguminosae) on vascular tone in rat thoracic aorta. Biological & pharmaceutical bulletin 28:1450-1454;(2005) (Pubitemid 41379697)
180. Zhang, B. Q.; Hu, S. J.; Qiu, L. H.; Zhu, J. H.; Xie, X. J.; Sun, J.; Zhu, Z. H.; Xia, Q.; Bian, K. Effects of Astragalus membranaceus and its main components on the acute phase endothelial dysfunction induced by homocysteine. Vascular pharmacology 46:278-285;(2007) (Pubitemid 46138051)
181. Bian, K.; Toda, N. Effects of sophoramine, an alkaloid from Sophora alopecuroides on isolated dog blood vessels. Journal of ethnopharmacology 24:167-178;(1988) (Pubitemid 19022064)
182. Gonzalez-Gallego, J.; Sanchez-Campos, S.; Tunon, M. J. Anti-inflammatory properties of dietary flavonoids. Nutr Hosp 22:287-293;(2007) (Pubitemid 46888658)
183. Menon, V. P.; Sudheer, A. R. Antioxidant and antiinflammatory properties of curcumin. Advances in experimental medicine and biology 595:105-125;(2007)
184. Suschek, C. V.; Schnorr, O.; Kolb-Bachofen, V. The role of iNOS in chronic inflammatory processes in vivo: is it damage-promoting, protective, or active at all? Current molecular medicine 4:763-775;(2004) (Pubitemid 39369294)
185. Brown, G. C.; Bal-Price, A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Molecular neurobiology 27:325-355;(2003) (Pubitemid 38156291)
186. Ricciardolo, F. L.; Nijkamp, F. P.; Folkerts, G. Nitric oxide synthase (NOS) as therapeutic target for asthma and chronic obstructive pulmonary disease. Current drug targets 7:721-735;(2006) (Pubitemid 43827268)
187. Sun, K. H.; Tang, S. J.; Chen, C. Y.; Lee, T. P.; Feng, C. K.; Yu, C. L.; Sun, G. H. Monoclonal ribosomal P autoantibody inhibits the expression and release of IL-12, TNF-alpha and iNOS in activated RAW macrophage cell line. Journal of autoimmunity 24:135-143;(2005)
188. Lui, S. L.; Tsang, R.; Wong, D.; Chan, K. W.; Chan, T. M.; Fung, P. C.; Lai, K. N. Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice. Lupus 11:411-418;(2002)
189. Belmont, H. M.; Levartovsky, D.; Goel, A.; Amin, A.; Giorno, R.; Rediske, J.; Skovron, M. L.; Abramson, S. B. Increased nitric oxide production accompanied by the upregulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus. Arthritis and rheumatism 40:1810-1816;(1997) (Pubitemid 27452531)
190. Carreras, M. C.; Franco, M. C.; Peralta, J. G.; Poderoso, J. J. Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease. Molecular aspects of medicine 25:125-139;(2004) (Pubitemid 38401937)
191. Murakami, A.; Ohigashi, H. Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. International journal of cancer 121:2357-2363;(2007) (Pubitemid 350022403)
192. Pance, A. Nitric oxide and hormones in breast cancer: allies or enemies? Future oncology (London, England) 2:275-288;(2006)
193. He, T.; Xing, Y. Q.; Zhao, X. H.; Ai, M. Interaction between iNOS and COX-2 in hypoxia-induced retinal neovascularization in mice. Archives of medical research 38:807-815;(2007) (Pubitemid 47513272)
194. Jung, H. J.; Kang, H. J.; Song, Y. S.; Park, E. H.; Kim, Y. M.; Lim, C. J. Anti-inflammatory, anti-angiogenic and antinociceptive activities of Sedum sarmentosum extract. Journal of ethnopharmacology 116:138-143;(2008)
195. McDaniel, M. L.; Kwon, G.; Hill, J. R.; Marshall, C. A.; Corbett, J. A. Cytokines and nitric oxide in islet inflammation and diabetes. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y 211:24-32;(1996)
196. Penberthy, W. T. Pharmacological targeting of IDO-mediated tolerance for treating autoimmune disease. Current drug metabolism 8:245-266;(2007) (Pubitemid 46621674)
197. Bian, K.; Harari, Y.; Zhong, M.; Lai, M.; Castro, G.; Weisbrodt, N.; Murad, F. Down-regulation of inducible nitricoxide synthase (NOS-2) during parasite-induced gut inflammation: a path to identify a selective NOS-2 inhibitor. Mol Pharmacol 59:939-947;(2001) (Pubitemid 32274023)
198. Bian, K.; Zhong, M.; Harari, Y.; Lai, M.; Weisbrodt, N.; Murad, F. Helminth regulation of host IL-4Ralpha/Stat6 signaling: mechanism underlying NOS-2 inhibition by Trichinella spiralis. Proc Natl Acad Sci U S A 102:3936-3941;(2005) (Pubitemid 40388535)